0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Invited Commentary | 
Joseph M. Galante, MD
JAMA Surg. 2014;149(4):370-371. doi:10.1001/jamasurg.2013.4002.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Cardiology
Original Investigation  | 
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events A Secondary Analysis of the PEGASUS-TIMI 54 Trial
Marc P. Bonaca, MD, MPH; Deepak L. Bhatt, MD, MPH; Ton Oude Ophuis, MD; et al.
JAMA Cardiology
Editorial  | 
Understanding the Adverse Effects of Ticagrelor in Practice
Christopher B. Granger, MD; Peter B. Berger, MD
JAMA Oncology
Original Investigation  | 
Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer
Alfred I. Neugut, MD, PhD; Xiaobo Zhong, MS; Jason D. Wright, MD; et al.
JAMA Cardiology
Brief Report  | 
Patients and Physicians Beliefs and Practices Regarding Adherence to Cardiovascular Medication
Rosemary Hines, BA; Neil J. Stone, MD